Crinetics PharmaceuticalsCRNX
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 234 institutions reported holding Crinetics Pharmaceuticals Inc. (CRNX) in their 13F filings, up 31 from Q1 2024. 47 opened new positions and 16 sold out. The largest holders were BlackRock Inc. ($279.1M), Driehaus Capital Management LLC ($273.8M) and Wellington Management Group LLP ($206.9M). 7 famous investors held it, including Stanley Druckenmiller (0.5% of Duquesne Family Office's portfolio), Steve Cohen (0.4% of Point72 Asset Management's portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Crinetics Pharmaceuticals Inc.
- CUSIP
- 22663K107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 47 | $86.6M |
| Exits | 16 | $47.1M |
All 13F filers, Q1 2024 → Q2 2024: 12,070,039 shares bought and 10,027,214 shares sold, net +2,042,825 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 234 holders
| BlackRock Inc. | 0.01% | Add +14.6% | 6,230,371 | $279.1M |
| Driehaus Capital Management LLC | 2.65% | Add +16.9% | 6,112,173 | $273.8M |
| Wellington Management Group LLP | 0.04% | Add +55.5% | 4,620,413 | $206.9M |
| Vanguard Group Inc. | 0.00% | Add +26.3% | 4,514,478 | $202.2M |
| T. Rowe Price Associates Inc. | 0.02% | Add +15.3% | 4,406,456 | $197.4M |
| EcoR1 Capital, LLC | 5.70% | No change | 4,155,375 | $186.1M |
| FMR LLC | 0.01% | Reduce -8.2% | 4,096,795 | $183.5M |
| State Street Corp. | 0.01% | Reduce -13.6% | 2,812,923 | $126.0M |
| Point72 Asset Management | 0.41% | Reduce -43.8% | 2,780,856 | $124.6M |
| Jennison Associates LLC | 0.08% | Reduce -1.3% | 2,780,144 | $124.5M |
| Paradigm Biocapital Advisors LP | 4.31% | Reduce -19.6% | 2,513,302 | $112.6M |
| Janus Henderson Group PLC | 0.06% | Add +24.1% | 2,455,661 | $110.0M |
| Geode Capital Management, LLC | 0.01% | Add +19.8% | 1,678,387 | $75.2M |
| Perceptive Advisors LLC | 1.60% | No change | 1,476,203 | $66.1M |
| Cormorant Asset Management, LP | 3.52% | Add +17.4% | 1,350,000 | $60.5M |
| T. Rowe Price Investment Management, Inc. | 0.04% | Reduce -49.3% | 1,347,210 | $60.3M |
| Orbimed Advisors LLC | 1.14% | Reduce -7.5% | 1,280,800 | $57.4M |
| First Light Asset Management, LLC | 4.71% | Reduce -29.0% | 1,200,508 | $53.8M |
| Artal Group S.A. | 1.23% | Reduce -23.3% | 1,066,064 | $47.7M |
| Novo Holdings A/S | 2.41% | Reduce -9.0% | 1,000,000 | $44.8M |
| Lord, Abbett & Co. LLC | 0.13% | Reduce -8.0% | 887,921 | $39.8M |
| Franklin Resources Inc. | 0.01% | Add +108.5% | 861,422 | $38.6M |
| Morgan Stanley | 0.00% | Add +37.0% | 838,625 | $37.6M |
| Eventide Asset Management, LLC | 0.56% | Reduce -30.6% | 735,088 | $32.9M |
| Schonfeld Strategic Advisors LLC | 0.23% | Add +383.1% | 653,557 | $29.3M |
| Goldman Sachs Group Inc. | 0.01% | Reduce -24.9% | 649,190 | $29.1M |
| Ensign Peak Advisors, Inc | 0.05% | Reduce -0.8% | 616,227 | $27.6M |
| Northern Trust Corp. | 0.00% | Add +0.8% | 606,037 | $27.1M |
| Charles Schwab Investment Management Inc. | 0.01% | Add +24.8% | 597,049 | $26.7M |
| Ikarian Capital, LLC | 8.23% | Reduce -8.5% | 588,818 | $26.4M |
| MPM Bioimpact LLC | 3.88% | Add +15.9% | 557,184 | $25.0M |
| Stempoint Capital LP | 7.26% | Reduce -11.1% | 551,095 | $24.7M |
| Dimensional Fund Advisors LP | 0.01% | Reduce -14.7% | 546,759 | $24.5M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.06% | Add +0.7% | 546,234 | $24.5M |
| Affinity Asset Advisors, LLC | 4.00% | Add +9.6% | 515,000 | $23.1M |
| Farallon Capital Management, L.L.C. | 0.13% | Add +9840.0% | 497,000 | $22.3M |
| Fiera Capital Corp | 0.07% | Add +1.0% | 480,409 | $21.5M |
| Saturn V Capital Management LP | 8.12% | Reduce -27.3% | 479,681 | $21.5M |
| Nuveen Asset Management, LLC | 0.01% | Reduce -16.4% | 462,766 | $20.7M |
| Fisher Asset Management | 0.01% | Add +2.0% | 444,670 | $19.9M |
| Hood River Capital Management LLC | 0.38% | New | 410,342 | $18.4M |
| Integral Health Asset Management, LLC | 1.78% | Add +23.1% | 400,000 | $17.9M |
| Qube Research & Technologies Ltd | 0.03% | Add +312.1% | 390,941 | $17.5M |
| Bank of New York Mellon Corp | 0.00% | Add +30.4% | 386,450 | $17.3M |
| GW&K Investment Management, LLC | 0.15% | Reduce -2.7% | 377,663 | $16.9M |
| First Turn Management, LLC | 2.69% | New | 369,302 | $16.5M |
| Laurion Capital Management LP | 0.51% | Reduce -44.3% | 350,766 | $15.7M |
| Walleye Capital LLC | 0.16% | Add +30.6% | 315,220 | $14.1M |
| Duquesne Family Office | 0.49% | No change | 309,000 | $13.8M |
| Bank of America Corp. | 0.00% | Reduce -14.6% | 305,169 | $13.7M |
| Pictet Asset Management Holding SA | 0.02% | Add +3112.0% | 300,868 | $13.5M |
| Rock Springs Capital Management LP | 0.39% | No change | 289,400 | $13.0M |
| JPMorgan Chase & Co. | 0.00% | Reduce -24.2% | 285,062 | $12.8M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +23.2% | 260,980 | $11.7M |
| Ghost Tree Capital, LLC | 3.74% | Add +20.0% | 240,000 | $10.7M |
| Voya Investment Management LLC | 0.01% | Add +380.7% | 236,773 | $10.6M |
| Victory Capital Management Inc. | 0.01% | Reduce -11.8% | 226,687 | $10.2M |
| TD Asset Management Inc | 0.01% | Reduce -12.8% | 204,998 | $9.2M |
| Deutsche Bank AG | 0.00% | Add +192.9% | 203,889 | $9.1M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | Reduce -68.2% | 201,048 | $9.0M |
| First Trust Advisors LP | 0.01% | Add +93.6% | 196,961 | $8.8M |
| Prudential Financial Inc. | 0.01% | Add +28.4% | 185,755 | $8.3M |
| UBS Group AG | 0.00% | Reduce -26.2% | 182,942 | $8.2M |
| Invesco Ltd. | 0.00% | Add +2.6% | 181,599 | $8.1M |
| New York State Common Retirement Fund | 0.01% | Add +9.3% | 166,742 | $7.5M |
| Maplelane Capital, LLC | 0.54% | New | 160,000 | $7.2M |
| Decheng Capital LLC | 2.17% | No change | 157,958 | $7.1M |
| Boothbay Fund Management, LLC | 0.23% | Reduce -7.1% | 150,924 | $6.8M |
| Moody Aldrich Partners LLC | 1.31% | Add +166.3% | 150,183 | $6.7M |
| Parkman Healthcare Partners LLC | 0.86% | Add +39.8% | 141,375 | $6.3M |
| Marshall Wace, LLP | 0.01% | New | 141,204 | $6.3M |
| New Leaf Venture Partners, L.L.C. | 7.68% | No change | 141,000 | $6.3M |
| Acuta Capital Partners, LLC | 5.10% | Add +72.4% | 135,141 | $6.1M |
| Senator Investment Group LP | 0.29% | New | 135,000 | $6.0M |
| Manufacturers Life Insurance Company, The | 0.01% | Add +21.7% | 131,063 | $5.9M |
| Swiss National Bank | 0.00% | Add +3.0% | 130,300 | $5.8M |
| Man Group plc | 0.02% | New | 125,714 | $5.6M |
| Citadel Advisors | 0.01% | Reduce -28.9% | 121,879 | $5.5M |
| Jane Street Group, LLC | 0.01% | Add +224.7% | 119,880 | $5.4M |
| Barclays PLC | 0.00% | Add +58.0% | 118,354 | $5.3M |
| ExodusPoint Capital Management, LP | 0.06% | Add +299.5% | 116,322 | $5.2M |
| Balyasny Asset Management L.P. | 0.01% | New | 114,637 | $5.1M |
| Rhumbline Advisers | 0.00% | Add +3.3% | 112,319 | $5.0M |
| Rafferty Asset Management, LLC | 0.02% | Reduce -48.3% | 112,169 | $5.0M |
| Pier Capital, LLC | 0.72% | Reduce -6.9% | 108,545 | $4.9M |
| Baker Bros. Advisors LP | 0.06% | New | 103,927 | $4.7M |
| Russell Investments Group, Ltd. | 0.01% | Add +99.5% | 102,394 | $4.6M |
| Alliancebernstein L.P. | 0.00% | Add +37.5% | 92,530 | $4.1M |
| Artia Global Partners LP | 0.99% | No change | 85,765 | $3.8M |
| Lisanti Capital Growth, LLC | 0.90% | Add +20.4% | 83,380 | $3.7M |
| SG Americas Securities, LLC | 0.02% | Add +1224.8% | 79,051 | $3.5M |
| Jefferies Financial Group Inc. | 0.07% | Add +1443.8% | 77,500 | $3.5M |
| ADAR1 Capital Management, LLC | 0.68% | New | 74,850 | $3.4M |
| Wells Fargo & Company | 0.00% | Add +5.9% | 72,920 | $3.3M |
| Legal & General Group Plc | 0.00% | Add +7.5% | 68,758 | $3.1M |
| Aberdeen Group plc | 0.01% | Reduce -34.6% | 66,196 | $3.0M |
| California State Teachers Retirement System | 0.00% | Add +1.9% | 65,536 | $2.9M |
| Alps Advisors Inc. | 0.02% | Add +11.9% | 61,525 | $2.8M |
| State of Wisconsin Investment Board | 0.01% | Add +20.6% | 60,416 | $2.7M |
| Informed Momentum Co LLC | 0.42% | Reduce -46.4% | 57,179 | $2.6M |
"% of holder's portfolio" is CRNX's weight in each manager's 13F, not the share of Crinetics Pharmaceuticals Inc. the manager owns.